>
Mosaic Immunoengineering, Inc. logo

CPMV - Mosaic Immunoengineering, Inc. Share Price

$3.03 0.0  0.0%

Last Trade - 07/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £16.0m
Enterprise Value £15.7m
Revenue £n/a
Position in Universe 6119th / 6827
Bullish
Bearish
Unlock CPMV Revenue
Momentum
Relative Strength (%)
1m -7.78%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -67.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st May 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 November 2020, MosaicImmunoengineering, Inc. revenues was not reported. Net lossdecreased 13% to $747K. Lower net loss reflects General andadministrative decrease of 49% to $405K (expense), Equityin loss of affiliated company decrease of 93% to $5K(expense). Basic Earnings per Share excluding ExtraordinaryItems decreased from -$1.07 to -$2.00.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CPMV Revenue Unlock CPMV Revenue

Net Income

CPMV Net Income Unlock CPMV Revenue

Normalised EPS

CPMV Normalised EPS Unlock CPMV Revenue

PE Ratio Range

CPMV PE Ratio Range Unlock CPMV Revenue

Dividend Yield Range

CPMV Dividend Yield Range Unlock CPMV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CPMV EPS Forecasts Unlock CPMV Revenue
Profile Summary

Mosaic ImmunoEngineering Inc., formerly Patriot Scientific Corporation, is a development-stage biotechnology company. The Company is focused on a platform technology using immunostimulatory nanotechnology-based therapeutics and vaccines to treat and prevent cancer and infectious diseases in humans and for veterinary use. Its core technology platform is based on Cowpea Mosaic Virus (CPMV), which is non-infectious to humans or other animals but upon intra-tumoral administration, elicits an innate immune response resulting in potent anti-tumor activity against the primary and distant tumor sites. Its lead oncology candidate is MI-O-101, which is being developed for the treatment of solid tumors. Its Modular Vaccine Platform (MVP) platform is designed to facilitate the rapid development of vaccine candidates due to its modular nature. It is also focused on developing MI-V-101 for the treatment of COVID-19.

Directors
Last Annual May 31st, 2020
Last Interim November 30th, 2020
Incorporated March 24, 1992
Public Since October 28, 1993
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 7,228,093
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
CPMV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CPMV
Upcoming Events for CPMV
Frequently Asked Questions for Mosaic Immunoengineering, Inc.
What is the Mosaic Immunoengineering, Inc. share price?

As of 07/04/21, shares in Mosaic Immunoengineering, Inc. are trading at $3.03, giving the company a market capitalisation of £16.0m. This share price information is delayed by 15 minutes.

How has the Mosaic Immunoengineering, Inc. share price performed this year?

Shares in Mosaic Immunoengineering, Inc. are currently trading at $3.03 and the price has moved by 209k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mosaic Immunoengineering, Inc. price has moved by 140k% over the past year.

What are the analyst and broker recommendations for Mosaic Immunoengineering, Inc.?

There are no analysts currently covering Mosaic Immunoengineering, Inc..

When will Mosaic Immunoengineering, Inc. next release its financial results?

Mosaic Immunoengineering, Inc. is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-11-30
What is the Mosaic Immunoengineering, Inc. dividend yield?

Mosaic Immunoengineering, Inc. does not currently pay a dividend.

Does Mosaic Immunoengineering, Inc. pay a dividend?

Mosaic Immunoengineering, Inc. does not currently pay a dividend.

When does Mosaic Immunoengineering, Inc. next pay dividends?

Mosaic Immunoengineering, Inc. does not currently pay a dividend.

How do I buy Mosaic Immunoengineering, Inc. shares?

To buy shares in Mosaic Immunoengineering, Inc. you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Mosaic Immunoengineering, Inc.?

Shares in Mosaic Immunoengineering, Inc. are currently trading at $3.03, giving the company a market capitalisation of £16.0m.

Where are Mosaic Immunoengineering, Inc. shares listed? Where are Mosaic Immunoengineering, Inc. shares listed?

Here are the trading details for Mosaic Immunoengineering, Inc.:

Country of listing: United States
Exchange: PNK
Ticker Symbol: CPMV
What kind of share is Mosaic Immunoengineering, Inc.?

Based on an overall assessment of its quality, value and momentum, Mosaic Immunoengineering, Inc. is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Mosaic Immunoengineering, Inc. share price forecast 2021?

We were not able to load any forecast data for Mosaic Immunoengineering, Inc..

How can I tell whether the Mosaic Immunoengineering, Inc. share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mosaic Immunoengineering, Inc.. Over the past six months, the relative strength of its shares against the market has been 73.1k%. At the current price of $3.03, shares in Mosaic Immunoengineering, Inc. are trading at 0.103k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Mosaic Immunoengineering, Inc. PE Ratio?

We were not able to find PE ratio data for Mosaic Immunoengineering, Inc..

Who are the key directors of Mosaic Immunoengineering, Inc.?

Mosaic Immunoengineering, Inc.'s management team is headed by:

Carlton Johnson - CHM
Gloria Felcyn - IND
Steven King - PRE
Paul Lytle - CFO
Nicole Steinmetz - CSO
Robert Garnick - DRC
Who are the major shareholders of Mosaic Immunoengineering, Inc.?

Here are the top five shareholders of Mosaic Immunoengineering, Inc. based on the size of their shareholding:

Steinmetz (Nicole Franziska) Individual Investor
Percentage owned: 22.71% (1.64m shares)
King (Steven W) Individual Investor
Percentage owned: 22.71% (1.64m shares)
Lytle (Paul J) Individual Investor
Percentage owned: 22.71% (1.64m shares)
Garnick Robert L Individual Investor
Percentage owned: 4.94% (357k shares)
Felcyn (Gloria H) Individual Investor
Percentage owned: 0.03% (1.90k shares)
Similar to CPMV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.